GGrantIndex
Sort

65,743 grants matching single cell sequencing

SBIR Phase II: Multiplexed Single Cell Analysis

$880,000
David S Johnson · Gigagen Inc. · · FY2012 · TIP

A new modality to image tumor metabolic heterogeneity at subcellular resolution

$879,890
Matthew Steinhauser · University Of Pittsburgh At Pittsburgh · DP2 · FY2016 · CA

Next-Generation Antibody Discovery and Development Technology

$879,836
David Scott Johnson · Gigagen, Inc. · R44 · FY2016 · CA

Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis

$879,804
Laura D Attardi · Stanford University · R35 · FY2024 · CA

Autoimmune Stem-like CD8 T cells in Type 1 Diabetes

$879,657
Andrea Schietinger · Sloan-Kettering Inst Can Research · R01 · FY2024 · AI

Resilience pathways modeling human longevity-promoting ApoE variants in induced pluripotent stem cells

$879,592
Lisa M. Ellerby · Buck Institute For Research On Aging · R01 · FY2018 · AG

Resilience pathways modeling human longevity-promoting ApoE variants in induced pluripotent stem cells

$879,592
Lisa M. Ellerby · Buck Institute For Research On Aging · R01 · FY2021 · AG

Resilience pathways modeling human longevity-promoting ApoE variants in induced pluripotent stem cells

$879,592
Lisa M. Ellerby · Buck Institute For Research On Aging · R01 · FY2020 · AG

Resilience pathways modeling human longevity-promoting ApoE variants in induced pluripotent stem cells

$879,592
Lisa M. Ellerby · Buck Institute For Research On Aging · R01 · FY2022 · AG

Resilience pathways modeling human longevity-promoting ApoE variants in induced pluripotent stem cells

$879,592
Lisa M. Ellerby · Buck Institute For Research On Aging · R01 · FY2019 · AG

Endolysins as tools to eradicate pneumococcal biofilms and development ofprotective immunity

$879,588
Norberto Gonzalez-Juarbe · Univ Of Maryland, College Park · R01 · FY2025 · AI

Discovery of Functional Variants in Type 2 Diabetes Genes in Mexican Americans

$879,580
Ravindranath Duggirala · Texas Biomedical Research Institute · U01 · FY2012 · DK

Regulation of Cardiac Development in Health and Disease

$879,536
Jonathan G Seidman · Harvard Medical School · UM1 · FY2017 · HL

Regulation of Cardiac Development in Health and Disease

$879,536
Jonathan G Seidman · Harvard Medical School · UM1 · FY2019 · HL

Regulation of Cardiac Development in Health and Disease

$879,536
Jonathan G Seidman · Harvard Medical School · UM1 · FY2016 · HL

Regulation of Cardiac Development in Health and Disease

$879,536
Jonathan G Seidman · Harvard Medical School · UM1 · FY2018 · HL

CANCER AND INFLAMMATION GENETICS

$879,352
Michael Dean · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Integrated Services Core

$879,285
William Paul Duprex · University Of Pittsburgh At Pittsburgh · UC7 · FY2024 · AI

Impact of Immunotherapy on Viral Immunity in Humans

$879,190
Raymond T Chung · Massachusetts General Hospital · U19 · FY2021 · AI

High-throughput mapping of antigen specificity to B-cell-receptor sequence for characterizing antibody responses in HIV-vaccinated and infected individuals

$879,020
Ivelin Georgiev · Vanderbilt University Medical Center · R01 · FY2020 · AI

Preventing GVHD by inhibition of alloantigen presentation in the gut

$878,801
Geoffrey Roger Hill · Fred Hutchinson Cancer Center · R01 · FY2025 · HL

Understanding Schizophrenia Risk Mechanisms Via Multimodal Analysis of Patient-derived Neurons and 3D Cortical Organoids and Correlation with Clinical and Cognitive Phenotypes

$878,597
Brady J Maher · Lieber Institute, Inc. · R01 · FY2025 · MH

Project 2: Susceptibility of Lung Cancer Cells to SARS- CoV-2 Infection and Antibody-Mediated Neutralization

$878,495
Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U54 · FY2020 · CA

EFIRM Liquid Biopsy Research Laboratory: Early Lung Cancer Assessment

$878,436
David T Wong · University Of California Los Angeles · U01 · FY2024 · CA

Structure and function of eukaryotic DNA transposases

$878,398
Frederick Dyda · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK